Annual Body Weight Change and Prognosis in Chronic Obstructive Pulmonary Disease

Int J Chron Obstruct Pulmon Dis. 2021 Nov 30:16:3243-3253. doi: 10.2147/COPD.S338908. eCollection 2021.

Abstract

Purpose: Low body mass index (BMI) has been reported to be associated with poor prognosis in patients with chronic obstructive pulmonary disease (COPD). In contrast, a detailed analysis of the association between body weight change over time and prognosis is not sufficient, particularly in Japanese patients with COPD who have been reported to be much thinner compared to Westerners. This study aimed to investigate the relationship between annual body weight change and long-term prognosis in Japanese patients with COPD in two independent cohorts.

Patients and methods: We analyzed 279 patients with COPD who participated in the Hokkaido COPD cohort study as a discovery cohort. We divided participants into three groups according to quartiles of annual body weight change calculated by the data from the first 5 years: weight loss group (<-0.17 kg/year), no change group (-0.17 to ≤0.20 kg/year), and weight gain group (>0.20 kg/year). The association between annual body weight change and prognosis was replicated in the Kyoto University cohort (n = 247).

Results: In the Hokkaido COPD cohort study, the weight loss group had significantly worse mortality than the other groups, whereas there was no difference in BMI at baseline. In the multivariate analysis, annual body weight change was an independent risk factor for all-cause mortality, which was confirmed in the Kyoto University cohort.

Conclusion: Annual body weight loss is associated with poor prognosis in Japanese patients with COPD, independent of baseline BMI. Longitudinal assessment of body weight is important for the management of COPD.

Keywords: annual body weight change; body mass index; chronic obstructive pulmonary disease; mortality; prognosis; weight loss.

MeSH terms

  • Body Mass Index
  • Body Weight
  • Cohort Studies
  • Humans
  • Prognosis
  • Pulmonary Disease, Chronic Obstructive*
  • Weight Loss

Grants and funding

The Hokkaido COPD cohort study was supported by a scientific research grant from the Japan Society for the Promotion of Science (17390239 and 2139053); a grant to the Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare, Japan; and from Boehringer-Ingelheim and Pfizer. The Kyoto University cohort was supported by the Japan Society for the Promotion of Science (16390234, 21590964, and 17H06807) and a grant to the Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan. The sponsors had no role in the design of the study, collection and analysis of data, or preparation of the manuscript.